Sitaxsentan (STX) improves ventricular synchrony in patients with pulmonary arterial hypertension (PAH)

被引：0
|
作者：
Pulido, T. [1 ]
Namendys-Silva, S. A. [1 ]
Vallejo, E. [1 ]
Jimenez, L. [1 ]
Moreno-Sanchez, P. [1 ]
Rueda, T. [1 ]
Bautista, E. [1 ]
Sandoval, J. [1 ]
机构：
[1] Natl Heart Inst, Mexico City, DF, Mexico
来源：
EUROPEAN HEART JOURNAL | 2006年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：625 / 625
页数：1
相关论文
共 50 条
  • [1] Sitaxsentan improves ventricular synchrony in patients with pulmonary arterial hypertension
    Vallejo, E.
    Pulido, T.
    Jimenez, L.
    Namendys-Silva, E.
    Moreno-Sanchez, P.
    Pena, H.
    Sandoval, J.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2009, 11 (0B) : S60 - S60
  • [2] Sitaxsentan improves time to clinical worsening in patients with pulmonary arterial hypertension (PAH).
    Badesch, D
    Galie, N
    Langleben, D
    Naeije, R
    Simonneau, G
    Barst, RJ
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S167 - S167
  • [3] Sitaxsentan improves time to clinical worsening (TCW) in patients with pulmonary arterial hypertension (PAH)
    Oudiz, R. J.
    Frost, A. E.
    Lawrence, E. C.
    Galie, N.
    Barst, R. J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (02): : S75 - S75
  • [4] Sitaxsentan improves time to clinical worsening (TCW) in patients with pulmonary arterial hypertension (PAH)
    Oudiz, RJ
    Frost, AE
    Lawrence, EC
    Galie, N
    Barst, RJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 307A - 307A
  • [5] Safety and efficacy of sitaxsentan in elderly patients with Pulmonary Arterial Hypertension (PAH)
    Vachiery, J. L.
    Sandoval-Zarate, J.
    Keogh, A.
    Kramer, M. R.
    Barst, R. J.
    Naeije, R.
    EUROPEAN HEART JOURNAL, 2006, 27 : 623 - 623
  • [6] Sitaxsentan improves time to clinical worsening in patients with pulmonary arterial hypertension
    Badesch, D
    Galie, N
    Langleben, D
    Naeije, R
    Simonneau, G
    Barst, R
    CHEST, 2005, 128 (04) : 160S - 161S
  • [7] Long-term sitaxsentan therapy in Pulmonary Arterial Hypertension (PAH)
    Horn, E
    Langleben, D
    Frost, A
    Hill, N
    McLaughlin, V
    Oudiz, R
    Dixon, RAF
    Barst, RJ
    EUROPEAN HEART JOURNAL, 2004, 25 : 466 - 466
  • [8] Sitaxsentan in pulmonary arterial hypertension
    Apostoloponlon, SC
    Rammos, S
    CHEST, 2003, 123 (05) : 1772 - 1772
  • [9] Sitaxsentan improves 6MW and hemodynamics in patients with pulmonary arterial hypertension (PAH) related to connective tissue disease (CTD)
    Girgis, R
    McLaughlin, V
    Hill, N
    Tapson, V
    Frost, A
    Langleben, D
    Oudiz, R
    Shapiro, S
    Robbins, I
    Barst, R
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 283 - 283
  • [10] Sitaxsentan improves 6MW in patients with pulmonary arterial hypertension (PAH) related to connective-tissue diseases (CTD)
    McLaughlin, VV
    Hill, N
    Tapson, V
    Frost, A
    Langleben, D
    Oudiz, R
    Shapiro, S
    Robbins, I
    Barst, RJ
    CHEST, 2004, 126 (04) : 759S - 759S
12345